Concepts (245)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart-Assist Devices | 31 | 2021 | 1288 | 3.660 |
Why?
|
| Extracorporeal Membrane Oxygenation | 12 | 2022 | 1462 | 2.300 |
Why?
|
| Shock, Cardiogenic | 6 | 2021 | 709 | 1.810 |
Why?
|
| Intra-Aortic Balloon Pumping | 3 | 2021 | 223 | 1.340 |
Why?
|
| Heart Transplantation | 11 | 2022 | 3258 | 1.310 |
Why?
|
| Mitral Valve | 18 | 2020 | 1465 | 1.270 |
Why?
|
| Heart Ventricles | 10 | 2021 | 3813 | 1.080 |
Why?
|
| Heart Valve Prosthesis Implantation | 6 | 2020 | 1555 | 0.870 |
Why?
|
| Ventricular Function, Left | 7 | 2021 | 3899 | 0.800 |
Why?
|
| Heart Failure | 21 | 2021 | 11701 | 0.770 |
Why?
|
| Aortic Valve Insufficiency | 3 | 2020 | 576 | 0.770 |
Why?
|
| Myocardial Contraction | 7 | 2011 | 1516 | 0.740 |
Why?
|
| Sternotomy | 2 | 2018 | 128 | 0.640 |
Why?
|
| Mitral Valve Insufficiency | 11 | 2021 | 1400 | 0.530 |
Why?
|
| Prosthesis Failure | 4 | 2019 | 1204 | 0.500 |
Why?
|
| Papillary Muscles | 4 | 2011 | 192 | 0.480 |
Why?
|
| Sheep | 21 | 2015 | 1436 | 0.480 |
Why?
|
| Purinergic P2Y Receptor Antagonists | 1 | 2016 | 284 | 0.460 |
Why?
|
| Propensity Score | 3 | 2020 | 1916 | 0.450 |
Why?
|
| Blood Loss, Surgical | 1 | 2016 | 637 | 0.410 |
Why?
|
| Models, Cardiovascular | 5 | 2012 | 983 | 0.410 |
Why?
|
| Thrombosis | 7 | 2018 | 2944 | 0.410 |
Why?
|
| Aortic Valve | 3 | 2020 | 1959 | 0.380 |
Why?
|
| Acute Kidney Injury | 2 | 2021 | 1923 | 0.370 |
Why?
|
| Aortic Aneurysm | 2 | 2017 | 648 | 0.360 |
Why?
|
| Finite Element Analysis | 5 | 2011 | 437 | 0.350 |
Why?
|
| Prosthesis Design | 6 | 2020 | 2114 | 0.340 |
Why?
|
| Combined Modality Therapy | 2 | 2021 | 8519 | 0.330 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2017 | 3627 | 0.300 |
Why?
|
| Retrospective Studies | 24 | 2022 | 80674 | 0.280 |
Why?
|
| Catheterization | 2 | 2022 | 1428 | 0.260 |
Why?
|
| Subclavian Steal Syndrome | 1 | 2005 | 20 | 0.250 |
Why?
|
| Cardiomyopathies | 1 | 2017 | 2021 | 0.230 |
Why?
|
| Treatment Outcome | 22 | 2021 | 64681 | 0.230 |
Why?
|
| Aorta, Thoracic | 1 | 2010 | 1096 | 0.230 |
Why?
|
| Prosthesis Implantation | 2 | 2020 | 590 | 0.220 |
Why?
|
| Takayasu Arteritis | 1 | 2005 | 105 | 0.220 |
Why?
|
| Adaptation, Physiological | 2 | 2009 | 1301 | 0.210 |
Why?
|
| Blood Vessel Prosthesis Implantation | 2 | 2010 | 1425 | 0.210 |
Why?
|
| Heart Valve Diseases | 1 | 2010 | 1031 | 0.210 |
Why?
|
| Fluoroscopy | 7 | 2011 | 947 | 0.210 |
Why?
|
| Tantalum | 3 | 2011 | 54 | 0.200 |
Why?
|
| Myocardial Ischemia | 4 | 2021 | 2133 | 0.200 |
Why?
|
| Tissue and Organ Procurement | 2 | 2021 | 963 | 0.200 |
Why?
|
| Ventricular Dysfunction, Right | 2 | 2019 | 629 | 0.190 |
Why?
|
| Middle Aged | 32 | 2021 | 220853 | 0.180 |
Why?
|
| Lung Transplantation | 2 | 2021 | 1307 | 0.180 |
Why?
|
| Ventricular Dysfunction, Left | 5 | 2018 | 2131 | 0.170 |
Why?
|
| Mitral Valve Annuloplasty | 1 | 2021 | 144 | 0.170 |
Why?
|
| Echocardiography | 5 | 2020 | 5006 | 0.170 |
Why?
|
| Hemodynamics | 9 | 2015 | 4165 | 0.170 |
Why?
|
| Elasticity | 3 | 2011 | 655 | 0.160 |
Why?
|
| Thoracotomy | 1 | 2020 | 366 | 0.160 |
Why?
|
| Humans | 51 | 2022 | 761208 | 0.160 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2019 | 103 | 0.150 |
Why?
|
| Female | 34 | 2021 | 392544 | 0.150 |
Why?
|
| Male | 40 | 2021 | 360693 | 0.150 |
Why?
|
| Aged | 25 | 2021 | 169288 | 0.150 |
Why?
|
| Technetium | 1 | 2018 | 326 | 0.150 |
Why?
|
| Adult | 27 | 2022 | 221119 | 0.150 |
Why?
|
| Systole | 6 | 2010 | 936 | 0.140 |
Why?
|
| Reoperation | 4 | 2020 | 4303 | 0.140 |
Why?
|
| Arteries | 1 | 2022 | 1121 | 0.140 |
Why?
|
| Postoperative Complications | 5 | 2021 | 15637 | 0.140 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2017 | 275 | 0.130 |
Why?
|
| Acidosis | 1 | 2017 | 269 | 0.130 |
Why?
|
| Electric Stimulation | 2 | 2012 | 1736 | 0.130 |
Why?
|
| Staining and Labeling | 2 | 2018 | 1080 | 0.120 |
Why?
|
| Oxygenators, Membrane | 1 | 2015 | 56 | 0.120 |
Why?
|
| Bronchitis | 1 | 2016 | 196 | 0.120 |
Why?
|
| Fibrin | 1 | 2018 | 507 | 0.120 |
Why?
|
| Hospital Costs | 1 | 2021 | 947 | 0.120 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 2016 | 130 | 0.120 |
Why?
|
| Foreign-Body Migration | 1 | 2016 | 220 | 0.120 |
Why?
|
| Abdominal Wall | 1 | 2016 | 166 | 0.120 |
Why?
|
| Registries | 3 | 2021 | 8247 | 0.120 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2011 | 1241 | 0.110 |
Why?
|
| Time Factors | 11 | 2020 | 39957 | 0.110 |
Why?
|
| Equipment Failure Analysis | 1 | 2016 | 846 | 0.110 |
Why?
|
| Cardiac Valve Annuloplasty | 1 | 2014 | 51 | 0.110 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2014 | 190 | 0.110 |
Why?
|
| Diastole | 3 | 2009 | 782 | 0.100 |
Why?
|
| Intention to Treat Analysis | 3 | 2019 | 413 | 0.100 |
Why?
|
| Abdominal Injuries | 1 | 2016 | 361 | 0.100 |
Why?
|
| Aortic Valve Stenosis | 1 | 2005 | 2018 | 0.100 |
Why?
|
| Proportional Hazards Models | 3 | 2021 | 12474 | 0.100 |
Why?
|
| Withholding Treatment | 1 | 2016 | 616 | 0.100 |
Why?
|
| Follow-Up Studies | 6 | 2020 | 39126 | 0.100 |
Why?
|
| Myocardium | 2 | 2018 | 4746 | 0.100 |
Why?
|
| Myocardial Revascularization | 1 | 2016 | 794 | 0.100 |
Why?
|
| Models, Animal | 4 | 2015 | 2115 | 0.100 |
Why?
|
| Databases, Factual | 4 | 2021 | 7966 | 0.100 |
Why?
|
| Heart | 3 | 2010 | 4431 | 0.100 |
Why?
|
| Excitation Contraction Coupling | 1 | 2011 | 25 | 0.100 |
Why?
|
| Parasympathetic Nervous System | 1 | 2012 | 143 | 0.100 |
Why?
|
| Extracellular Matrix | 3 | 2015 | 1720 | 0.100 |
Why?
|
| Abdomen | 1 | 2017 | 1128 | 0.100 |
Why?
|
| Preoperative Care | 1 | 2020 | 2241 | 0.090 |
Why?
|
| Video Recording | 3 | 2011 | 965 | 0.090 |
Why?
|
| Hemolysis | 1 | 2013 | 415 | 0.090 |
Why?
|
| Stress, Mechanical | 3 | 2011 | 1674 | 0.090 |
Why?
|
| Coronary Artery Bypass | 1 | 2020 | 2193 | 0.090 |
Why?
|
| Survival Rate | 3 | 2021 | 12728 | 0.090 |
Why?
|
| Graft Survival | 1 | 2021 | 3843 | 0.090 |
Why?
|
| Ventricular Pressure | 1 | 2011 | 210 | 0.090 |
Why?
|
| Pulmonary Artery | 1 | 2019 | 1929 | 0.090 |
Why?
|
| Sheep, Domestic | 1 | 2009 | 50 | 0.080 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2014 | 353 | 0.080 |
Why?
|
| Hospital Mortality | 2 | 2020 | 5295 | 0.080 |
Why?
|
| Vagus Nerve | 1 | 2012 | 458 | 0.080 |
Why?
|
| Torsion, Mechanical | 1 | 2009 | 15 | 0.080 |
Why?
|
| Hypovolemia | 1 | 2009 | 48 | 0.080 |
Why?
|
| Ischemia | 1 | 2017 | 1889 | 0.080 |
Why?
|
| Vascular Surgical Procedures | 1 | 2017 | 1489 | 0.080 |
Why?
|
| Surgical Wound Infection | 1 | 2018 | 1530 | 0.080 |
Why?
|
| Propanolamines | 1 | 2009 | 163 | 0.080 |
Why?
|
| Risk Factors | 6 | 2021 | 74239 | 0.080 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 6504 | 0.080 |
Why?
|
| Animals | 23 | 2018 | 168079 | 0.070 |
Why?
|
| Decision Support Techniques | 1 | 2018 | 2004 | 0.070 |
Why?
|
| Incidence | 3 | 2021 | 21365 | 0.070 |
Why?
|
| Atrial Fibrillation | 1 | 2006 | 5114 | 0.070 |
Why?
|
| Stroke | 6 | 2019 | 9721 | 0.070 |
Why?
|
| Respiratory Insufficiency | 1 | 2016 | 1232 | 0.070 |
Why?
|
| Graft Rejection | 1 | 2020 | 4481 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2019 | 6486 | 0.070 |
Why?
|
| Pancreatitis | 1 | 2013 | 1081 | 0.070 |
Why?
|
| Aged, 80 and over | 9 | 2020 | 58952 | 0.060 |
Why?
|
| Equipment Failure | 2 | 2020 | 580 | 0.060 |
Why?
|
| Disease Progression | 2 | 2020 | 13511 | 0.060 |
Why?
|
| Risk Assessment | 4 | 2020 | 24021 | 0.060 |
Why?
|
| Muscle, Smooth | 1 | 2009 | 927 | 0.060 |
Why?
|
| Clinical Competence | 1 | 2020 | 4788 | 0.060 |
Why?
|
| Wound Healing | 1 | 2015 | 2800 | 0.060 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2009 | 4052 | 0.060 |
Why?
|
| Mitral Valve Stenosis | 1 | 2006 | 341 | 0.060 |
Why?
|
| Collagen | 2 | 2009 | 2635 | 0.060 |
Why?
|
| Ventricular Remodeling | 2 | 2008 | 1270 | 0.060 |
Why?
|
| Macrophages | 1 | 2018 | 5753 | 0.050 |
Why?
|
| Stroke Volume | 3 | 2011 | 5521 | 0.050 |
Why?
|
| Aorta, Abdominal | 1 | 2005 | 625 | 0.050 |
Why?
|
| Epidemiologic Methods | 1 | 2006 | 1336 | 0.050 |
Why?
|
| Acute Disease | 4 | 2016 | 7226 | 0.050 |
Why?
|
| Survival Analysis | 3 | 2020 | 10088 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2009 | 6223 | 0.050 |
Why?
|
| Heart Valve Prosthesis | 1 | 2009 | 1463 | 0.040 |
Why?
|
| Regional Blood Flow | 2 | 2017 | 1498 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2018 | 5333 | 0.040 |
Why?
|
| Tissue Donors | 2 | 2021 | 2335 | 0.040 |
Why?
|
| Coronary Artery Disease | 2 | 2020 | 6505 | 0.040 |
Why?
|
| Elastic Modulus | 2 | 2012 | 211 | 0.040 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2011 | 2787 | 0.040 |
Why?
|
| Microscopy, Video | 2 | 2011 | 241 | 0.040 |
Why?
|
| Severity of Illness Index | 4 | 2018 | 15841 | 0.040 |
Why?
|
| Triiodothyronine | 1 | 2021 | 492 | 0.040 |
Why?
|
| Hypertension | 2 | 2020 | 8536 | 0.040 |
Why?
|
| Smoking | 1 | 2016 | 9055 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2017 | 20588 | 0.040 |
Why?
|
| Learning Curve | 1 | 2020 | 230 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2015 | 830 | 0.040 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2005 | 1432 | 0.040 |
Why?
|
| Likelihood Functions | 1 | 2021 | 991 | 0.040 |
Why?
|
| Brain Death | 1 | 2021 | 357 | 0.040 |
Why?
|
| Disease-Free Survival | 2 | 2019 | 6819 | 0.040 |
Why?
|
| Models, Anatomic | 2 | 2011 | 683 | 0.040 |
Why?
|
| Receptors, CCR2 | 1 | 2018 | 214 | 0.040 |
Why?
|
| Thyroxine | 1 | 2021 | 665 | 0.040 |
Why?
|
| Age Factors | 3 | 2020 | 18384 | 0.040 |
Why?
|
| Acid-Base Equilibrium | 1 | 2017 | 181 | 0.030 |
Why?
|
| Anisotropy | 2 | 2011 | 1284 | 0.030 |
Why?
|
| Asthma | 1 | 2016 | 6230 | 0.030 |
Why?
|
| Waiting Lists | 1 | 2021 | 766 | 0.030 |
Why?
|
| Half-Life | 1 | 2018 | 649 | 0.030 |
Why?
|
| Missouri | 1 | 2016 | 115 | 0.030 |
Why?
|
| Mediastinitis | 1 | 2016 | 49 | 0.030 |
Why?
|
| Weight-Bearing | 1 | 2018 | 532 | 0.030 |
Why?
|
| Patient Care Planning | 1 | 2020 | 901 | 0.030 |
Why?
|
| Blood Pressure | 3 | 2018 | 8479 | 0.030 |
Why?
|
| Multivariate Analysis | 2 | 2020 | 12052 | 0.030 |
Why?
|
| Walking | 1 | 2021 | 1194 | 0.030 |
Why?
|
| Quality of Life | 3 | 2021 | 13367 | 0.030 |
Why?
|
| Suture Techniques | 2 | 2009 | 768 | 0.030 |
Why?
|
| Recurrence | 1 | 2006 | 8457 | 0.030 |
Why?
|
| Comorbidity | 2 | 2020 | 10516 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 2018 | 1664 | 0.030 |
Why?
|
| Mycoses | 1 | 2016 | 386 | 0.030 |
Why?
|
| Blood Flow Velocity | 1 | 2016 | 1375 | 0.030 |
Why?
|
| Antibodies | 1 | 2020 | 2415 | 0.020 |
Why?
|
| Myocytes, Cardiac | 2 | 2011 | 1666 | 0.020 |
Why?
|
| Young Adult | 4 | 2020 | 59221 | 0.020 |
Why?
|
| Device Removal | 1 | 2016 | 629 | 0.020 |
Why?
|
| Contrast Media | 3 | 2010 | 5311 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2021 | 2159 | 0.020 |
Why?
|
| Streptococcus pneumoniae | 1 | 2016 | 730 | 0.020 |
Why?
|
| Prospective Studies | 3 | 2021 | 54435 | 0.020 |
Why?
|
| Disease Models, Animal | 4 | 2009 | 18220 | 0.020 |
Why?
|
| Decorin | 1 | 2008 | 38 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2015 | 11067 | 0.020 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2008 | 81 | 0.020 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2016 | 1048 | 0.020 |
Why?
|
| Risk | 1 | 2020 | 9616 | 0.020 |
Why?
|
| Equipment Design | 1 | 2016 | 3510 | 0.020 |
Why?
|
| Pressure | 1 | 2011 | 1155 | 0.020 |
Why?
|
| Computer Simulation | 2 | 2012 | 6224 | 0.020 |
Why?
|
| Length of Stay | 1 | 2021 | 6417 | 0.020 |
Why?
|
| ROC Curve | 1 | 2015 | 3584 | 0.020 |
Why?
|
| Elastin | 1 | 2008 | 298 | 0.020 |
Why?
|
| Dilatation, Pathologic | 1 | 2008 | 527 | 0.020 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2011 | 698 | 0.020 |
Why?
|
| Adolescent | 3 | 2020 | 88298 | 0.020 |
Why?
|
| Renal Dialysis | 1 | 2016 | 1796 | 0.020 |
Why?
|
| Matrix Metalloproteinases | 1 | 2008 | 392 | 0.020 |
Why?
|
| Surgical Instruments | 1 | 2008 | 383 | 0.020 |
Why?
|
| Protein Binding | 1 | 2018 | 9297 | 0.020 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 3201 | 0.020 |
Why?
|
| Cause of Death | 1 | 2016 | 3688 | 0.020 |
Why?
|
| Proteoglycans | 1 | 2008 | 803 | 0.020 |
Why?
|
| Cardiotonic Agents | 1 | 2008 | 540 | 0.010 |
Why?
|
| Patient Readmission | 1 | 2019 | 3265 | 0.010 |
Why?
|
| Respiration, Artificial | 1 | 2016 | 2631 | 0.010 |
Why?
|
| Ventricular Function, Right | 1 | 2008 | 618 | 0.010 |
Why?
|
| Fluorescein Angiography | 1 | 2009 | 1062 | 0.010 |
Why?
|
| Sex Factors | 1 | 2017 | 10553 | 0.010 |
Why?
|
| Heart Atria | 1 | 2009 | 1349 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2016 | 41496 | 0.010 |
Why?
|
| Artifacts | 1 | 2011 | 1912 | 0.010 |
Why?
|
| Chronic Disease | 2 | 2008 | 9319 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2020 | 12952 | 0.010 |
Why?
|
| Coronary Circulation | 1 | 2008 | 1611 | 0.010 |
Why?
|
| Patient Discharge | 1 | 2014 | 3441 | 0.010 |
Why?
|
| Lung | 1 | 2019 | 9979 | 0.010 |
Why?
|
| Dopamine | 1 | 2008 | 1601 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2015 | 10422 | 0.010 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2008 | 1725 | 0.010 |
Why?
|
| United States | 2 | 2020 | 72339 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2008 | 4111 | 0.010 |
Why?
|
| Algorithms | 2 | 2011 | 14025 | 0.010 |
Why?
|
| Hospitalization | 1 | 2018 | 10707 | 0.010 |
Why?
|
| Inflammation | 1 | 2018 | 10759 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2009 | 5250 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2011 | 5081 | 0.010 |
Why?
|
| Heart Rate | 1 | 2008 | 4197 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2011 | 8998 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 20119 | 0.010 |
Why?
|
| Mice | 1 | 2018 | 81326 | 0.010 |
Why?
|
Concepts
(245)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(6)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_